CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential...
63 insider purchases on record · latest filing 2026-08-26.
Insiders have also filed 47 sale transactions at CVM.